MKI67 and neoplasm: Analysis of tumor proliferation via Ki67 revealed no difference in proliferation rates between CD83KO and control tumors, whereas CD83OE tumors demonstrated significantly reduced proliferative capacities (5.5% Ki67 CD83OE, 10.27% Ki67 CD83KO, 9.3% Ki67 control, one-way ANOVA P value = 0.0133.